Product Management Group
← The PMG Journal

MOQ and Manufacturing Volume: What Actually Matters (And Why Your Numbers Might Be Wrong)

Minimums are the first hard number most brands run into, and the one most often misread. Here is what sits behind them, and how to plan a first run you can sell through.

Almost every new brand hits the same wall in the same week. You have a formula you like, a package you like, and a manufacturer who likes the project — and then a minimum order quantity lands in the quote that is three or ten times the number you had in your spreadsheet. It reads like a gatekeeping tactic. It usually is not.

MOQ is arithmetic, not attitude. Understanding the arithmetic is what lets you negotiate it, work around it, or decide the project needs a different path entirely.

What MOQ is, and why it exists

A minimum order quantity is the smallest run a manufacturer will produce for a given specification. It exists because a large share of the cost of making anything does not move with the number of units. Cleaning and validating a line before your batch costs the same whether you fill five thousand units or fifty thousand. Setting up a filler, changing tooling, running the first units to waste while the fill weight settles, testing the batch, running the line down and cleaning it again for the next customer — all fixed.

Raw materials behave the same way. Actives, fragrances, and specialty ingredients are sold in drums and sacks with their own minimums. Components are worse: a custom bottle, a custom closure, a printed carton, and a decorated label each carry their own tooling and print-run minimums, often set by a different supplier than the one filling your product.

So the MOQ you are quoted is rarely one number. It is the highest of several minimums stacked on top of each other — the filler's, the chemist's, the bottle vendor's, the printer's. That matters, because it tells you where to push.

MOQ varies more by category and method than by size

Two products of identical volume can carry wildly different minimums. The drivers are the format and the process, not the ounces.

  • Format. A liquid filled into a stock bottle is one of the most flexible formats there is. Gummies, tablets, capsules, aerosols, and anything requiring a compression, encapsulation, or pressurization step carry higher minimums because the equipment is harder to change over.
  • Formula ownership. Running a lab's existing stock formula is cheap to start. A custom formula developed for you means bench work, stability, and a bulk batch sized to the equipment — which sets a floor of its own.
  • Regulatory class. An OTC monograph product runs in a facility with batch record, testing, and release requirements that do not scale down. Minimums follow.
  • Packaging decisions. Stock components with stock caps keep you flexible. A custom mold, a metallized label, a unit carton, or a decorated bottle can each set a higher minimum than the fill itself.
  • SKU count. Five shades or five flavors is five changeovers, five component sets, and five minimums — not one order split five ways. This is the single most common way brands accidentally multiply their commitment.

The costs that appear when volume is below minimum

Manufacturers will sometimes run below their stated minimum. It is worth knowing what that actually costs before you ask, because the price rarely shows up as a single line item.

  • Fixed costs spread thinner. The same setup, cleaning, and testing cost divided across fewer units. This is the whole game, and it can move per-unit cost dramatically.
  • Short-run or changeover surcharges. A direct fee that compensates for the line time you are occupying.
  • Component overbuy. If the bottle vendor's minimum is higher than your fill, you pay for components you will store — or scrap if artwork changes.
  • Material waste. Small batches leave more bulk in the tank and lines proportionally. Expensive actives make that waste expensive.
  • Scheduling position. Small runs get slotted around large ones. The cost is lead time, and lead time is a cost when you have a launch date.
  • Requoting at scale. A price built on a small run tells you almost nothing about your real margin later. It is a common reason a brand's unit economics look fine at launch and break at growth.

MOQ alignment by development path

The most useful way to think about minimums is not "how low can this go" but "which path am I on." Each path carries a different floor, and the trade is always flexibility against ownership.

  • Stock formula, stock packaging. Lowest minimums, fastest path to market, least differentiation. You do not own the formula, and neither does anyone else — a competitor can buy the same base.
  • Stock formula with modifications. A fragrance change, a color, an active at a different level. Minimums rise modestly; distinctiveness rises meaningfully. For most first launches, this is the sweet spot. We walk through the trade-offs here.
  • Custom formulation. Bench development, stability, and a bulk batch sized to equipment. Higher minimums and a longer runway, in exchange for a formula that is yours. See how R&D structures that work.
  • OTC and regulated categories. Monograph compliance, batch records, and release testing set a floor that is largely non-negotiable. Plan volume around the regulatory requirement, not the other way around.
  • Custom packaging or custom delivery format. Tooling is a one-time cost amortized over units, which is simply another way of saying it sets a minimum. Ask what the tooling costs and who owns it.

Volume planning: the questions that matter

A minimum is only a problem relative to what you can sell. Before you argue the number down, get honest about the demand side.

  • What is realistic monthly sell-through in the first 90 days, based on evidence you already have rather than the launch you are picturing?
  • If you sell half of what you expect, how many months of inventory is this order?
  • If you sell double, what is the reorder lead time, and can you survive being out of stock?
  • What is the shelf life, and how much of it will be gone by the time the last unit ships?
  • Does this order lock in artwork, claims, or packaging you may still want to change?
  • Are you buying volume for a retail or distributor commitment that exists in writing — or one that exists in a conversation?

Common mistakes

  • Comparing fill cost instead of landed cost. A low per-unit quote that excludes components, freight, duty, testing, and storage is not a comparison. Insist every quote is landed.
  • Launching with too many SKUs. Range breadth feels like a stronger launch and behaves like a multiplied minimum. Launch narrow, extend once something sells.
  • Buying to a price break you cannot sell through. A better unit cost on inventory that ages out is not savings. Shelf life is a hard constraint, particularly in supplements and anything with actives.
  • Ignoring cash. Deposits are typically due at PO, with the balance before release. That cash is out of the business for the whole production and sell-through cycle, which is often the real limit — not the minimum.
  • Forgetting where it all goes. A full run needs somewhere to sit and someone to ship it. Storage and fulfillment belong in the volume decision, not after it.
  • Treating the first quote as final. It is an opening position built on assumptions you have not yet challenged.

How to negotiate MOQ productively

The brands who get movement do not ask for a smaller number. They give the manufacturer a reason the economics still work.

  • Ask for three volumes, not one. Quote the same spec at your minimum, your target, and a stretch. The curve tells you where the real breaks are and where the fixed costs sit.
  • Ask which lines are fixed. Once you know whether the constraint is the filler, the bulk batch, or a component vendor, you know which one to solve.
  • Commit to the follow-on. A smaller first run against a contracted second run is a very different conversation than a one-off.
  • Buy components at volume, fill in stages. Often the packaging minimum is the binding one. Purchasing components once and filling in waves gets you the price without the finished-goods risk — where shelf life and storage allow.
  • Simplify the specification. Stock closure instead of custom. One size instead of three. A label instead of a decorated bottle. Each removal takes a minimum off the stack.
  • Be straight about your forecast. A manufacturer sizing equipment and materials around a real number will work harder for you than one who gets a number chosen to impress them.

Before you commit to a volume

  • The quote is landed cost per unit, not fill cost.
  • Margin still works at the volume you can genuinely sell, not the volume that makes the math look good.
  • The cash committed leaves runway for marketing, reorders, and the things that go wrong.
  • Shelf life comfortably exceeds projected sell-through.
  • Artwork, claims, and labeling are final and reviewed.
  • Reorder pricing and lead time are written down, not implied.
  • Tooling ownership and leftover components are addressed in writing.
  • Storage and fulfillment for the full quantity are arranged before it lands.

Sources and references

FDA (Food and Drug Administration) regulations and guidance

USP and standards

  • United States Pharmacopeia (USP). (2024). USP 1150 — Analytical Data: Interpretation and Acceptance Criteria. In: USP 47 — NF 42 (United States Pharmacopeia / National Formulary). Rockville, MD: USP.
  • United States Pharmacopeia (USP). USP Standards for Dietary Supplements. Available at: https://www.usp.org/standards/dietary-supplements

Manufacturing and industry data

  • Industry data sourced from Flexport (3PL rates, 2024), ShipBob (fulfillment benchmarks, 2024), and interviews with regional cosmetic and supplement co-manufacturers (2023–2024).
  • Stability testing costs and timelines based on standard industry practices for cosmetics per USP and regulatory guidance.
  • MOQ ranges and batch setup costs derived from co-manufacturer surveys and published industry data (2023–2024).

Key industry statistics

  • Fixed batch costs ($2,000 to $15,000): averages derived from cosmetic and supplement manufacturing facilities serving brands with volumes under 50,000 units per year.
  • Per-unit overhead calculations: based on standard absorption accounting for typical batch sizes and production methods.
  • 3PL storage rates ($0.50 to $1.50 per unit per month): current market rates from major fulfillment networks (2024).
  • Stability testing (6 to 12 months): standard timelines for topical products per USP 1150 and FDA guidance.
  • OTC compliance costs: estimated based on FDA Drug Establishment Registration, labeler registration, and ongoing batch record requirements per 21 CFR Part 211.

Additional references

  • Handbook of Cosmetic Science and Technology (3rd ed.). CRC Press. Comprehensive overview of formulation MOQs and manufacturing economics.
  • Regulatory guidance on supplement manufacturing timelines from the Natural Products Association and the American Herbal Pharmacopoeia.
Companion worksheet

MOQ Planning Worksheet

Use this worksheet to calculate per-unit costs at different volumes, model cash flow impact, and work through the pre-launch checklist.

PDF · 3 pages

Still unsure what volume your project actually needs? Tell us what you are making and we will walk the numbers with you.